DRCT was introduced to the board by Hweb in the $3's, long before that short report. At that time it was very arguably a 50/50 chance of legitimacy. Gilead also did some good research on it. Safe to say it was an excellent risk/reward buy in the $3's .... certainly NOT a pure gamble as you called it. You have to understand probabilities. I didn't have time for much due diligence, so just bought a small position. Yes, that short attack has some merit so it seems a higher probability of being a scam now, but not 90%, though clearly it's very risky at $15.